Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-05-05 @ 9:43 PM
Study NCT ID:
NCT07400458
Status:
RECRUITING
Last Update Posted:
2026-02-10
First Post:
2024-05-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Long-term Follow-up Study Following the Approval of Hearticellgram-AMI Administration
Sponsor:
Pharmicell Co., Ltd.
Organization:
Study Overview
Official Title:
Long-term Follow-up Study Following the Approval of Hearticellgram-AMI Administration to Evaluate Its Safety in Patients With Acute Myocardial Infarction
Status:
RECRUITING
Status Verified Date:
2026-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This Long-term follow-up is designed to evaluate the safety of patient with Acute Myocardial Infarction who had administered Hearticellgram-AMI.
Detailed Description:
To evaluate the safety for 60 months after a single dose of Hearticellgram-AMI in patients with Acute Myocardial Infarction.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?: